Abstract
Pulmonary fibrosis is an interstitial disorder of the lung parenchyma whose mechanism is poorly understood. Potential mechanisms include the infiltration of inflammatory cells to the lungs and the generation of pro-inflammatory mediators. In particular, idiopathic pulmonary fibrosis is a progressive and fatal form of the disorder characterized by alveolar inflammation, fibroblast proliferation and collagen deposition. Here, we investigated the role of cytosolic phospholipase A2 (cPLA2) in pulmonary fibrosis using cPLA2-null mutant mice, as cPLA2 is a key enzyme in the generation of pro-inflammatory eicosanoids. Disruption of the gene encoding cPLA2 (Pla2g4a) attenuated IPF and inflammation induced by bleomycin administration. Bleomycin-induced overproduction of thromboxanes and leukotrienes in lung was significantly reduced in cPLA2-null mice. Our data suggest that cPLA2 has an important role in the pathogenesis of pulmonary fibrosis. The inhibition of cPLA2-initiated pathways might provide a novel therapeutic approach to pulmonary fibrosis, for which no pharmaceutical agents are currently available.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
American Thoracic Society. Idiopathic pulmonary fibrosis: Diagnosis and treatment; international consensus statement. Am. J. Respir. Crit. Care Med. 161, 646–664 (2000).
Wilborn, J. et al. Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis. J. Clin. Invest. 97, 1827–1836 (1996).
Lan Tran, P. et al. Prevention of bleomycin-induced pulmonary fibrosis after adenovirus-mediated transfer of the bacterial bleomycin resistance gene. J. Clin. Invest. 99, 608–617 (1997).
Eitzman, D.T. et al. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J. Clin. Invest. 97, 232–237 (1996).
Hattori, N. et al. Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice. J. Clin. Invest. 106, 1341–1350 (2000).
Prescott, S.M., Zimmerman, G.A. & McIntyre, T.M. Platelet-activating factor. J. Biol. Chem. 265, 17381–17384 (1990).
Chao, W. & Olson, M.S. Platelet-activating factor: Receptors and signal transduction. Biochem. J. 292, 617–629 (1993).
Izumi, T. & Shimizu, T. Platelet-activating factor receptor: Gene expression and signal transduction. Biochim. Biophys. Acta. 1259, 317–333 (1995).
Honda, Z. et al. Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature 349, 342–346 (1991).
Nakamura, M. et al. Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. J. Biol. Chem. 266, 20400–20405 (1991).
Ye, R.D., Prossnitz, E.R., Zou, A.H. & Cochrane, C.G. Characterization of a human cDNA that encodes a functional receptor for platelet activating factor. Biochem. Biophys. Res. Commun. 180, 105–111 (1991).
Kunz, D., Gerard, N.P. & Gerard, C. The human leukocyte platelet-activating factor receptor. cDNA cloning, cell surface expression & construction of a novel epitope-bearing analog. J. Biol. Chem. 267, 9101–9106 (1992).
Sugimoto, T. et al. Molecular cloning and characterization of the platelet-activating factor receptor gene expressed in the human heart. Biochem. Biophys. Res. Commun. 189, 617–624 (1992).
Bito, H., Honda, Z. -i, Nakamura, M. & Shimizu, T. Cloning, expression and tissue distribution of rat platelet-activating-factor-receptor cDNA. Eur. J. Biochem. 221, 211–218 (1994).
Ishii, S. et al. A murine platelet-activating factor receptor gene: Cloning, chromosomal localization and up-regulation of expression by lipopolysaccharide in peritoneal resident macrophages. Biochem. J. 314, 671–678 (1996).
Ishii, S. et al. Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor. EMBO J. 16, 133–142 (1997).
Ishii, S. et al. Impaired anaphylactic responses but intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor. J. Exp. Med. 187, 1779–1788 (1998).
Leslie, C.C. Properties and regulation of cytosolic phospholipase A2 . J. Biol. Chem. 272, 16709–16712 (1997).
Clark, J.D. et al. A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-de-pendent translocation domain with homology to PKC and GAP. Cell 65, 1043–1051 (1991).
Sharp, J.D. et al. Molecular cloning and expression of human Ca2+-sensitive cytosolic phospholipase A2 . J. Biol. Chem. 266, 14850–14853 (1991).
Lin, L.L. et al. cPLA2 is phosphorylated and activated by MAP kinase. Cell 72, 269–278 (1993).
Kramer, R.M. et al. p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets. J. Biol. Chem. 271, 27723–27729 (1996).
Uozumi, N. et al. Roles of cytosolic phospholipase A2 in allergic response and parturition. Nature 390, 618–622 (1997).
Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y. & Shimizu, T. A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature 387, 620–624 (1997).
Chiang, N. et al. Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion. J. Clin. Invest. 104, 309–316 (1999).
Levy, B.D., Clish, C.B., Schmidt, B., Gronert, K. & Serhan, C.N. Lipid mediator class switching during acute inflammation: Signals in resolution. Nature Immunol. 2, 612–619 (2001).
Lynch, K.R. et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 399, 789–793 (1999).
Dahlen, S.E. et al. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules; in vitro effects with relevance to the acute inflammatory response. Proc. Natl. Acad. Sci. USA. 78, 3887–3891 (1981).
Nagase, T. et al. Acute lung injury by sepsis and acid aspiration: A key role for cytosolic phospholipase A2 . Nature Immunol. 1, 42–46 (2000).
Sleijfer, S. Bleomycin-induced pneumonitis. Chest 120, 617–624 (2001).
Loehrer, P.J., Johnson, D., Elson, P., Einhorn, L.H. & Trump, D. Importance of bleomycin in favorable-prognosis disseminated germ cell tumors. An Eastern Cooperative Oncology Group Trial. J. Clin. Oncol. 13, 470–476 (1995).
Scheule, R.K., Perkins, R.C., Hamilton, R. & Holian, A. Bleomycin stimulation of cytokine secretion by the human alveolar macrophage. Am. J. Physiol. 262, L386–L391 (1992).
Moseley, P.L., Hemken, C. & Hunninghake, G.W. Augmentation of fibroblast proliferation by bleomycin. J. Clin. Invest. 78, 1150–1154 (1986).
Ishii, S. & Shimizu, T. Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog. Lipid Res. 39, 41–82 (2000).
Shindou, H., Ishii, S., Uozumi, N. & Shimizu, T. Roles of cytosolic phospholipase A2 and platelet-activating factor receptor in the Ca-induced biosynthesis of PAF. Biochem. Biophys. Res. Commun. 271, 812–817 (2000).
Nagase, T., Ishii, S., Shindou, H., Ouchi, Y. & Shimizu, T. Airway hyperresponsiveness in transgenic mice overexpressing platelet-activating factor receptor is mediated by an atropine-sensitive pathway. Am. J. Respir. Crit. Care Med. 165, 200–205 (2002).
Nagase, T., Aoki, T., Oka, T., Fukuchi, Y. & Ouchi, Y. ET-1-induced bronchoconstriction is mediated via ETB receptor in mice. J. Appl. Physiol. 83, 46–51 (1997).
Nagase, T. et al. Airway hyperresponsiveness to methacholine in mutant mice deficient in endothelin-1. Am. J. Respir. Crit. Care Med. 157, 560–564 (1998).
Nagase, T. et al. Airway responsiveness in transgenic mice overexpressing platelet-activating factor receptor: Roles of thromboxanes and leukotrienes. Am. J. Respir. Crit. Care Med. 156, 1621–1627 (1997).
Nagase, T. et al. Platelet-activating factor mediates acid-induced lung injury in genetically engineered mice. J. Clin. Invest. 104, 1071–1076 (1999).
Acknowledgements
We thank Y. Tateno, R. Mitsuzono, M. Yoshino, C. Ohkawara, T. Sato, H. Shiozawa, Y. Matsumoto and M. Ito for technical assistance; and F. Takaku and T. Yokomizo for valuable suggestions. This work was supported in part by grants-in-aid from the Ministry of Education, Science, Sports and Culture of Japan, and grants from the Human Science Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Nagase, T., Uozumi, N., Ishii, S. et al. A pivotal role of cytosolic phospholipase A2 in bleomycin-induced pulmonary fibrosis. Nat Med 8, 480–484 (2002). https://doi.org/10.1038/nm0502-480
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm0502-480
This article is cited by
-
Orientational screening of ssDNA-templated silver nanoclusters and application for bleomycin assay
Colloid and Polymer Science (2021)
-
Cytosolic phospholipase A2 contributes to innate immune defense against Candida albicans lung infection
BMC Immunology (2016)
-
Cytosolic phospholipase A2 plays a crucial role in ROS/NO signaling during microglial activation through the lipoxygenase pathway
Journal of Neuroinflammation (2015)
-
Effectiveness of the ICare rebound tonometer in patients with overestimated intraocular pressure due to tight orbit syndrome
Japanese Journal of Ophthalmology (2014)
-
A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice
Respiratory Research (2010)